Fibromyalgia and sarcopenia relation; the role of nutritional approach
Article Sidebar
Main Article Content
Abstract
Introduction: fibromyalgia (FM) is a syndrome charcaterized by the presence of chronic, and generalized musculoskeletal pain, not articular in origin, which can become disabling and affect the biological, psychological, and social sphere of the patient.
State of the art: no specific nutritional recommendations have been published for people with FM and there is also a vague knowledge regarding parameters related to body composition assessment (skeletal muscle mass, body fat mass, water, etc.) and loss of muscle strength (for example, dynapenia, by handgrip , knee flexion, among others), as well as assessment in terms of sarcopenia.
Discussion: there are few studies published so far that completely describe the body composition in people with FM. Most of them focus almost exclusively on weight and body mass index (BMI), so there is a lack of knowledge about other descriptive parameters, such as those related to muscle mass and strength or fat mass. Diet is mentioned in several publications, but there are no specific guidelines for nutritional recommendations for this population. Some patients follow several diets, strategies or eating plans without health care professionals’ guidance, and sometimes even following unreliable sources of information, putting themselves at risk. Scientific publications do not evaluate the association or impact of nutritional status and inadequate nutrition on quality of life in FM.
Conclusions: in people with FM, knowledge of the nutritional status, beyond weight, determining body composition and the prevalence of dynapenia and/or sarcopenia would allow a more accurate nutritional approach. This knowledge could be helpful for the treatment, achieving an improvement in their physical performance and a better quality of life.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Livshits G, Kalinkovich A. Specialized, pro-resolving mediators as potential therapeutic agents for alleviating fibromyalgia symptomatology. Pain Med. 2022;23(5):977-990. https://doi.org/10.1093/pm/pnab060. DOI: https://doi.org/10.1093/pm/pnab060
Sociedad Argentina de Reumatología. Guías argentinas de práctica clínica en el diagnóstico y tratamiento de la fibromialgia. Buenos Aires: Revista Argentina de Reumatología; 2016. 2-68.
Aparicio VA, Ortega FB, Heredia JM, et al. Análisis de la composición corporal en mujeres con fibromialgia [Analysis of the body composition of Spanish women with fibromyalgia]. Reumatol Clin. 2011;7(1):7-12. https://doi.org/10.1016/j.reuma.2010.05.006.
Koca I, Savas E, Ozturk ZA, et al. The evaluation in terms of sarcopenia of patients with fibromyalgia syndrome. Wien Klin Wochenschr. 2016;128(21-22):816-821. https://doi.org/10.1007/s00508-015-0821-8.
Rossi A, Di Lollo AC, Guzzo MP, et al. Fibromyalgia and nutrition: what news? Clin Exp Rheumatol. 2015;33(1 Suppl 88):S117-125.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. https://doi.org/10.1093/ageing/afq034. DOI: https://doi.org/10.1093/ageing/afq034
Gil Hernández Á, Sánchez de Medina Contreras F. Tratado de nutrición. 2ª ed. Madrid: Médica Panamericana; 2010.
Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36(1):49-64. https://doi.org/10.1016/j.clnu.2016.09.004. DOI: https://doi.org/10.1016/j.clnu.2016.09.004
Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr. 1993;123(2 Suppl):465-468. https://doi.org/10.1093/jn/123.suppl_2.465. DOI: https://doi.org/10.1093/jn/123.suppl_2.465
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;;48(1):16-31. https://doi.org/10.1093/ageing/afy169. Errata en: Age Ageing. 2019;48(4):601. https://doi.org/10.1093/ageing/afz046. DOI: https://doi.org/10.1093/ageing/afz046
GBD 2013 Risk Factors Collaborators, Forouzanfar MH, Alexander L, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287-323. https://doi.org/10.1016/S0140-6736(15)00128-2. DOI: https://doi.org/10.1016/S0140-6736(15)00128-2
Hawkes C, Ruel MT, Salm L, et al. Double-duty actions: seizing programme and policy opportunities to address malnutrition in all its forms. Lancet. 2020;395(10218):142-155. https://doi.org/10.1016/S0140-6736(19)32506-1. Errata en: Lancet. 2020;395(10221):338. https://doi.org/10.1016/S0140-6736(20)30065-9. DOI: https://doi.org/10.1016/S0140-6736(19)32506-1
Arranz LI, Canela MÁ, Rafecas M. Dietary aspects in fibromyalgia patients: results of a survey on food awareness, allergies, and nutritional supplementation. Rheumatol Int. 2012;32(9):2615-2621. https://doi.org/10.1007/s00296-011-2010-z. DOI: https://doi.org/10.1007/s00296-011-2010-z
Arranz LI, Canela MA, Rafecas M. Fibromyalgia and nutrition, what do we know? Rheumatol Int. 2010;30(11):1417-1427. https://doi.org/10.1007/s00296-010-1443-0. DOI: https://doi.org/10.1007/s00296-010-1443-0
Bennett RM, Jones J, Turk DC, et al. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27. https://doi.org/10.1186/1471-2474-8-27. DOI: https://doi.org/10.1186/1471-2474-8-27
Ursini F, Naty S, Grembiale RD. Fibromyalgia and obesity: the hidden link. Rheumatol Int. 2011;31(11):1403-1408. https://doi.org/10.1007/s00296-011-1885-z. DOI: https://doi.org/10.1007/s00296-011-1885-z
Organización Mundial de la Salud. Obesidad y sobrepeso [Internet]. Ginebra: OMS; 2021 jun 9 [citado 2022 mayo 15]. Disponible en: http://www.who.int/mediacentre/factsheets/fs311/es/.
Shapiro JR, Anderson DA, Danoff-Burg S. A pilot study of the effects of behavioral weight loss treatment on fibromyalgia symptoms. J Psychosom Res. 2005;59(5):275-282. https://doi.org/10.1016/j.jpsychores.2005.06.081. DOI: https://doi.org/10.1016/j.jpsychores.2005.06.081
Neumann L, Lerner E, Glazer Y, et al. A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol. 2008;27(12):1543-1547. https://doi.org/10.1007/s10067-008-0966-1. DOI: https://doi.org/10.1007/s10067-008-0966-1
Gonzalez MC, Correia MITD, Heymsfield SB. A requiem for BMI in the clinical setting. Curr Opin Clin Nutr Metab Care. 2017 Sep;20(5):314-321. doi: 10.1097/MCO.0000000000000395. DOI: https://doi.org/10.1097/MCO.0000000000000395
Rusu C, Gee ME, Lagacé C, et al. Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators. Health Promot Chronic Dis Prev Can. 2015;35(1):3-11. https://doi.org/10.24095/hpcdp.35.1.02. DOI: https://doi.org/10.24095/hpcdp.35.1.02
Alammar M, Alsoghayer S, El-Abd K, et al. Diagnostic accuracy of Body Mass Index (BMI) when diagnosing obesity in a saudi adult population in a primary care setting, cross sectional, retrospective study. Diabetes Metab Syndr Obes. 2020;13:2515-2520. https://doi.org/10.2147/DMSO.S263063. DOI: https://doi.org/10.2147/DMSO.S263063
Sayer AA, Robinson SM, Patel HP, et al. New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing. 2013;42(2):145-150. https://doi.org/10.1093/ageing/afs191. DOI: https://doi.org/10.1093/ageing/afs191
English KL, Paddon-Jones D. Protecting muscle mass and function in older adults during bed rest. Curr Opin Clin Nutr Metab Care. 2010;13(1):34-39. https://doi.org/10.1097/MCO.0b013e328333aa66. DOI: https://doi.org/10.1097/MCO.0b013e328333aa66
Shafiee G, Keshtkar A, Soltani A, et al. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16:21. https://doi.org/10.1186/s40200-017-0302-x. DOI: https://doi.org/10.1186/s40200-017-0302-x
Pareja JL, Martín F, Berná G, et al. Fibromyalgia: a search for markers and their evaluation throughout a treatment. Eur Sci J. 2015; Special Edition 11(10):426-434.
Morley JE, Bauer JM. Editorial: the future of sarcopenia. Curr Opin Clin Nutr Metab Care. 2019;22(1):1-3. https://doi.org/10.1097/MCO.0000000000000531. DOI: https://doi.org/10.1097/MCO.0000000000000531
Larsson L, Degens H, Li M, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019;99(1):427-511. https://doi.org/10.1152/physrev.00061.2017. DOI: https://doi.org/10.1152/physrev.00061.2017
Demling RH. Nutrition, anabolism, and the wound healing process: an overview. Eplasty. 2009;9:e9..
Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci. 1995;50 Spec No:5-8. https://doi.org/10.1093/gerona/50a.special_issue.5. DOI: https://doi.org/10.1093/gerona/50A.Special_Issue.5
Aparicio VA, Ortega FB, Heredia JM, et al. Análisis de la composición corporal en mujeres con fibromialgia [Analysis of the body composition of Spanish women with fibromyalgia]. Reumatol Clin. 2011;7(1):7-12. https://doi.org/10.1016/j.reuma.2010.05.006. DOI: https://doi.org/10.1016/j.reuma.2010.05.006
Koca I, Savas E, Ozturk ZA, et al. The evaluation in terms of sarcopenia of patients with fibromyalgia syndrome. Wien Klin Wochenschr. 2016;128(21-22):816-821. https://doi.org/10.1007/s00508-015-0821-8. DOI: https://doi.org/10.1007/s00508-015-0821-8
Arranz L, Canela MA, Rafecas M. Relationship between body mass index, fat mass and lean mass with SF-36 quality of life scores in a group of fibromyalgia patients. Rheumatol Int. 2012;32(11):3605-3611. https://doi.org/10.1007/s00296-011-2250-y. DOI: https://doi.org/10.1007/s00296-011-2250-y
Kapuczinski A, Soyfoo MS, De Breucker S, et al. Assessment of sarcopenia in patients with fibromyalgia. Rheumatol Int. 2022;42(2):279-284. https://doi.org/10.1007/s00296-021-04973-6. DOI: https://doi.org/10.1007/s00296-021-04973-6
Consenso SEEDO'2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Sociedad Española para el Estudio de la Obesidad] [SEEDO'2000 consensus for the evaluation of overweight and obesity and the establishment of criteria for therapeutic intervention. Sociedad Española para el Estudio de la Obesidad]. Med Clin (Barc). 2000;115(15):587-597. DOI: https://doi.org/10.1016/S0025-7753(00)71632-0